The first explanation is a weak effect of polymorphisms that reached a borderline significance level at the one-time point but were not seen at another time point.
← all excerpts
Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease.
1
—
—